chr2-71515635-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_001130987.2(DYSF):c.772G>A(p.Val258Met) variant causes a missense change. The variant allele was found at a frequency of 0.000203 in 1,613,910 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V258V) has been classified as Likely benign.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.772G>A | p.Val258Met | missense_variant | 8/56 | ENST00000410020.8 | |
DYSF | NM_003494.4 | c.676G>A | p.Val226Met | missense_variant | 7/55 | ENST00000258104.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.772G>A | p.Val258Met | missense_variant | 8/56 | 1 | NM_001130987.2 | A1 | |
DYSF | ENST00000258104.8 | c.676G>A | p.Val226Met | missense_variant | 7/55 | 1 | NM_003494.4 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251368Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135876
GnomAD4 exome AF: 0.000207 AC: 302AN: 1461712Hom.: 1 Cov.: 31 AF XY: 0.000221 AC XY: 161AN XY: 727162
GnomAD4 genome AF: 0.000171 AC: 26AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74400
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 20, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 25, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 07, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 21, 2020 | - - |
Qualitative or quantitative defects of dysferlin Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2022 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 226 of the DYSF protein (p.Val226Met). This variant is present in population databases (rs150345121, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. ClinVar contains an entry for this variant (Variation ID: 259085). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYSF protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at